[1] Alrashdan MS, Cirillo N, Mccullough M.Oral lichen planus: a literature review and update[J]. Arch Dermatol Res, 2016, 308(8): 539-551. [2] Baek K, Choi Y.The microbiology of oral lichen planus: is microbial infection the cause of oral lichen planus?[J]. Mol Oral Microbiol, 2018, 33(1): 22-28. [3] Du G, Wang Y, Chen J, et al.Potential association between Fusobacterium nucleatum enrichment on oral mucosal surface and oral lichen planus[J]. Oral Dis, 2020, 26(1): 122-130. [4] Han YW.Fusobacterium nucleatum: a commensal-turned pathogen[J]. Curr Opin Microbiol, 2015, 23: 141-147. [5] Toyofuku M, Nomura N, Eberl L.Types and origins of bacterial membrane vesicles[J]. Nat Rev Microbiol, 2019, 17(1): 13-24. [6] Brunner Pm, Leung Dym, Guttman-Yassky E.Immunologic, microbial, and epithelial interactions in atopic dermatitis[J]. Ann Allergy Asthma Immunol, 2018, 120(1): 34-41. [7] Takahashi N, Sulijaya B, Yamaha-Hara M, et al.Gingival epithelial barrier: regulation by beneficial and harmful microbes[J]. Tissue Barriers, 2019, 7(3): e1651158. [8] Günzel D, Yu AS.Claudins and the modulation of tight junction permeability[J]. Physiol Rev, 2013, 93(2): 525-569. [9] Hämäläinen L, Soiny Y, Pasonen-Seppänen S, et al.Alterations in the expression of EMT-related proteins claudin-1, claudin-4 and claudin-7, E-cadherin, TWIST1 and ZEB1 in oral lichen planus[J]. J Oral Pathol Med, 2019, 48(8): 735-744. [10] Yang M, Liu X, Luo Q, et al.An efficient method to isolate lemon derived extracellular vesicles for gastric cancer therapy[J]. J Nanobiotechnology, 2020, 18(1): 100-110. [11] Groeger S, Jarzina F, Windhorst A, et al.Influence of retinoic acid on human gingival epithelial barriers[J]. J Periodontal Res, 2016, 51(6): 748-757. [12] Michikawa H, Fujita-Yoshigaki J, Sugiya H.Enhancement of barrier function by overexpression of claudin-4 in tight junctions of submandibular gland cells[J]. Cell Tissue Res, 2008, 334(2): 255-264. [13] Liu W, Li M.The role of claudin-4 in the development of gastric cancer[J]. Scand J Gastroenterol, 2020, 55(9): 1072-1078. [14] Yang G, Seok JK, Kang H, et al.Skin barrier abnormalities and immune dysfunction in atopic dermatitis[J]. Int J Mol Sci, 2020, 21(8): 2867-2881. [15] Liu H, Hong X, Sun T, et al.Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation[J]. J Dig Dis, 2020, 21(7): 385-398. [16] Groeger S, Doman E, Chakraborty T, et al.Effects of Porphyromonas gingivalis infection on human gingival epithelial barrier function in vitro [J]. Eur J Oral Sci, 2010, 118(6): 582-589. [17] Maerz JK, Steimle A, Lange A, et al.Outer membrane vesicles blebbing contributes to B. vulgatus mpk-mediated immune response silencing[J]. Gut Microbes, 2018, 9(1): 1-12. [18] Chmiela M, Walczak N, Rudnicka K.Helicobacter pylori outer membrane vesicles involvement in the infection development and Helicobacter pylori-related diseases[J]. J Biomed Sci, 2018, 25(1): 78-89. [19] He Y, Shiotsu N, Uchida-Fukuhara Y, et al.Outer membrane vesicles derived from Porphyromonas gingivalis induced cell death with disruption of tight junctions in human lung epithelial cells[J]. Arch Oral Biol, 2020, 118: 104841. [20] Alvarez CS, Badia J, Bosch M, et al.Outer membrane vesicles and soluble factors released by probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 enhance barrier function by regulating expression of tight junction proteins in intestinal epithelial cells[J]. Front Microbiol, 2016, 7: 1981-1995. [21] Martin-Gallausiaux C, Malabirade A, Habier J, et al.Fusobacterium nucleatum extracellular vesicles modulate gut epithelial cell innate immunity via FomA and TLR2[J]. Front Immunol, 2020, 11: 583644. |